 | • レポートコード：D005-12356 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肺炎治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。肺炎治療薬の種類別市場規模（マクロライド、セファロスポリン、ペニシリン、テトラサイクリン、フルオロキノロン、バンコマイシン、その他の抗生物質、免疫療法薬、ワクチン、インターフェロン）、用途別市場規模（病院、クリニック、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、AstraZeneca、Novartis、MSD、Arsanis、Mylan、Shinogi、Teva Pharmaceutical、Pfizer、Combioxin、Sun Pharmaceutical、Theravance Biopharma、Teva Pharmaceutical、Medicines ・地域別グローバル市場分析 2015年-2020年 ・肺炎治療薬の北米市場（アメリカ、カナダ、メキシコ） ・肺炎治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肺炎治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肺炎治療薬の南米市場（ブラジル、アルゼンチン） ・肺炎治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：マクロライド、セファロスポリン、ペニシリン、テトラサイクリン、フルオロキノロン、バンコマイシン、その他の抗生物質、免疫療法薬、ワクチン、インターフェロン ・用途別分析：病院、クリニック、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pneumonia Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pneumonia Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pneumonia Treatment Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pneumonia Treatment Drugs market has been segmented into
Macrolides
Cephalosporin
Penicillin
Tetracyclines
Fluoroquinolones
Vancomycin
Other Antibiotics
Immunotherapy Drug
Vaccines
Interferon
By Application, Pneumonia Treatment Drugs has been segmented into:
Hospital
Clinic
Drugstore
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumonia Treatment Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumonia Treatment Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumonia Treatment Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Pneumonia Treatment Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pneumonia Treatment Drugs Market Share Analysis
Pneumonia Treatment Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumonia Treatment Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumonia Treatment Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Pneumonia Treatment Drugs are:
GlaxoSmithKline
AstraZeneca
Novartis
MSD
Arsanis
Mylan
Shinogi
Teva Pharmaceutical
Pfizer
Combioxin
Sun Pharmaceutical
Theravance Biopharma
Teva Pharmaceutical
Medicines
Among other players domestic and global, Pneumonia Treatment Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumonia Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumonia Treatment Drugs, with price, sales, revenue and global market share of Pneumonia Treatment Drugs in 2018 and 2019.
Chapter 3, the Pneumonia Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumonia Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pneumonia Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pneumonia Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pneumonia Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumonia Treatment Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Macrolides
1.2.3 Cephalosporin
1.2.4 Penicillin
1.2.5 Tetracyclines
1.2.6 Fluoroquinolones
1.2.7 Vancomycin
1.2.8 Other Antibiotics
1.2.9 Immunotherapy Drug
1.2.10 Vaccines
1.2.11 Interferon
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumonia Treatment Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Overview of Global Pneumonia Treatment Drugs Market
1.4.1 Global Pneumonia Treatment Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 MSD
2.4.1 MSD Details
2.4.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MSD SWOT Analysis
2.4.4 MSD Product and Services
2.4.5 MSD Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Arsanis
2.5.1 Arsanis Details
2.5.2 Arsanis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Arsanis SWOT Analysis
2.5.4 Arsanis Product and Services
2.5.5 Arsanis Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shinogi
2.7.1 Shinogi Details
2.7.2 Shinogi Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shinogi SWOT Analysis
2.7.4 Shinogi Product and Services
2.7.5 Shinogi Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical SWOT Analysis
2.8.4 Teva Pharmaceutical Product and Services
2.8.5 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Combioxin
2.10.1 Combioxin Details
2.10.2 Combioxin Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Combioxin SWOT Analysis
2.10.4 Combioxin Product and Services
2.10.5 Combioxin Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sun Pharmaceutical
2.11.1 Sun Pharmaceutical Details
2.11.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sun Pharmaceutical SWOT Analysis
2.11.4 Sun Pharmaceutical Product and Services
2.11.5 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Theravance Biopharma
2.12.1 Theravance Biopharma Details
2.12.2 Theravance Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Theravance Biopharma SWOT Analysis
2.12.4 Theravance Biopharma Product and Services
2.12.5 Theravance Biopharma Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Teva Pharmaceutical
2.13.1 Teva Pharmaceutical Details
2.13.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Teva Pharmaceutical SWOT Analysis
2.13.4 Teva Pharmaceutical Product and Services
2.13.5 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Medicines
2.14.1 Medicines Details
2.14.2 Medicines Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Medicines SWOT Analysis
2.14.4 Medicines Product and Services
2.14.5 Medicines Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pneumonia Treatment Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pneumonia Treatment Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumonia Treatment Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Pneumonia Treatment Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pneumonia Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumonia Treatment Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pneumonia Treatment Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
4.5 South America Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pneumonia Treatment Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Pneumonia Treatment Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Pneumonia Treatment Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pneumonia Treatment Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumonia Treatment Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pneumonia Treatment Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
6.3 UK Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
6.4 France Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pneumonia Treatment Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pneumonia Treatment Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pneumonia Treatment Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7.5 India Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pneumonia Treatment Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Pneumonia Treatment Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Pneumonia Treatment Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pneumonia Treatment Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pneumonia Treatment Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pneumonia Treatment Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pneumonia Treatment Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Pneumonia Treatment Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Pneumonia Treatment Drugs Price by Type (2015-2020)
11 Global Pneumonia Treatment Drugs Market Segment by Application
11.1 Global Pneumonia Treatment Drugs Sales Market Share by Application (2015-2020)
11.2 Global Pneumonia Treatment Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Pneumonia Treatment Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pneumonia Treatment Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Pneumonia Treatment Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Pneumonia Treatment Drugs Market Forecast (2021-2025)
12.2.2 Europe Pneumonia Treatment Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pneumonia Treatment Drugs Market Forecast (2021-2025)
12.2.4 South America Pneumonia Treatment Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pneumonia Treatment Drugs Market Forecast (2021-2025)
12.3 Pneumonia Treatment Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Pneumonia Treatment Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Pneumonia Treatment Drugs Market Share Forecast by Type (2021-2025)
12.4 Pneumonia Treatment Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Pneumonia Treatment Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Pneumonia Treatment Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pneumonia Treatment Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumonia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumonia Treatment Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Pneumonia Treatment Drugs Major Business
Table 9. GlaxoSmithKline Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline SWOT Analysis
Table 11. GlaxoSmithKline Pneumonia Treatment Drugs Product and Services
Table 12. GlaxoSmithKline Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Pneumonia Treatment Drugs Major Business
Table 15. AstraZeneca Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 16. AstraZeneca SWOT Analysis
Table 17. AstraZeneca Pneumonia Treatment Drugs Product and Services
Table 18. AstraZeneca Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Pneumonia Treatment Drugs Major Business
Table 21. Novartis Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Pneumonia Treatment Drugs Product and Services
Table 24. Novartis Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. MSD Basic Information, Manufacturing Base and Competitors
Table 26. MSD Pneumonia Treatment Drugs Major Business
Table 27. MSD Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 28. MSD SWOT Analysis
Table 29. MSD Pneumonia Treatment Drugs Product and Services
Table 30. MSD Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Arsanis Basic Information, Manufacturing Base and Competitors
Table 32. Arsanis Pneumonia Treatment Drugs Major Business
Table 33. Arsanis Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Arsanis SWOT Analysis
Table 35. Arsanis Pneumonia Treatment Drugs Product and Services
Table 36. Arsanis Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mylan Basic Information, Manufacturing Base and Competitors
Table 38. Mylan Pneumonia Treatment Drugs Major Business
Table 39. Mylan Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Mylan SWOT Analysis
Table 41. Mylan Pneumonia Treatment Drugs Product and Services
Table 42. Mylan Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Shinogi Basic Information, Manufacturing Base and Competitors
Table 44. Shinogi Pneumonia Treatment Drugs Major Business
Table 45. Shinogi Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Shinogi SWOT Analysis
Table 47. Shinogi Pneumonia Treatment Drugs Product and Services
Table 48. Shinogi Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Pneumonia Treatment Drugs Major Business
Table 51. Teva Pharmaceutical Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Teva Pharmaceutical SWOT Analysis
Table 53. Teva Pharmaceutical Pneumonia Treatment Drugs Product and Services
Table 54. Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Pneumonia Treatment Drugs Major Business
Table 57. Pfizer Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Pneumonia Treatment Drugs Product and Services
Table 60. Pfizer Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Combioxin Basic Information, Manufacturing Base and Competitors
Table 62. Combioxin Pneumonia Treatment Drugs Major Business
Table 63. Combioxin Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Combioxin SWOT Analysis
Table 65. Combioxin Pneumonia Treatment Drugs Product and Services
Table 66. Combioxin Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Pneumonia Treatment Drugs Major Business
Table 69. Sun Pharmaceutical Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Sun Pharmaceutical SWOT Analysis
Table 71. Sun Pharmaceutical Pneumonia Treatment Drugs Product and Services
Table 72. Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 74. Theravance Biopharma Pneumonia Treatment Drugs Major Business
Table 75. Theravance Biopharma Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Theravance Biopharma SWOT Analysis
Table 77. Theravance Biopharma Pneumonia Treatment Drugs Product and Services
Table 78. Theravance Biopharma Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceutical Pneumonia Treatment Drugs Major Business
Table 81. Teva Pharmaceutical Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Teva Pharmaceutical SWOT Analysis
Table 83. Teva Pharmaceutical Pneumonia Treatment Drugs Product and Services
Table 84. Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Medicines Basic Information, Manufacturing Base and Competitors
Table 86. Medicines Pneumonia Treatment Drugs Major Business
Table 87. Medicines Pneumonia Treatment Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Medicines SWOT Analysis
Table 89. Medicines Pneumonia Treatment Drugs Product and Services
Table 90. Medicines Pneumonia Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Pneumonia Treatment Drugs Sales by Manufacturer (2018-2019) (MT)
Table 92. Global Pneumonia Treatment Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Pneumonia Treatment Drugs Sales by Regions (2015-2020) (MT)
Table 94. Global Pneumonia Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 95. Global Pneumonia Treatment Drugs Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Pneumonia Treatment Drugs Sales by Countries (2015-2020) (MT)
Table 97. North America Pneumonia Treatment Drugs Sales Market Share by Countries (2015-2020)
Table 98. North America Pneumonia Treatment Drugs Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 100. Europe Pneumonia Treatment Drugs Sales by Countries (2015-2020) (MT)
Table 101. Europe Pneumonia Treatment Drugs Sales Market Share by Countries (2015-2020)
Table 102. Europe Pneumonia Treatment Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Pneumonia Treatment Drugs Sales by Regions (2015-2020) (MT)
Table 104. Asia-Pacific Pneumonia Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Pneumonia Treatment Drugs Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Pneumonia Treatment Drugs Sales by Countries (2015-2020) (MT)
Table 107. South America Pneumonia Treatment Drugs Sales Market Share by Countries (2015-2020)
Table 108. South America Pneumonia Treatment Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Pneumonia Treatment Drugs Sales by Countries (2015-2020) (MT)
Table 111. Middle East & Africa Pneumonia Treatment Drugs Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Pneumonia Treatment Drugs Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020)
Table 114. Global Pneumonia Treatment Drugs Sales by Type (2015-2020) (MT)
Table 115. Global Pneumonia Treatment Drugs Sales Share by Type (2015-2020)
Table 116. Global Pneumonia Treatment Drugs Revenue by Type (2015-2020) (USD Million)
Table 117. Global Pneumonia Treatment Drugs Revenue Share by Type (2015-2020)
Table 118. Global Pneumonia Treatment Drugs Sales by Application (2015-2020) (MT)
Table 119. Global Pneumonia Treatment Drugs Sales Share by Application (2015-2020)
Table 120. Global Pneumonia Treatment Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 121. Global Pneumonia Treatment Drugs Market Share Forecast by Regions (2021-2025)
Table 122. Global Pneumonia Treatment Drugs Sales Forecast by Type (2021-2025) (MT)
Table 123. Global Pneumonia Treatment Drugs Market Share Forecast by Type (2021-2025)
Table 124. Global Pneumonia Treatment Drugs Sales Forecast by Application (2021-2025)
Table 125. Global Pneumonia Treatment Drugs Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pneumonia Treatment Drugs Picture
Figure 2. Global Sales Market Share of Pneumonia Treatment Drugs by Type in 2019
Figure 3. Macrolides Picture
Figure 4. Cephalosporin Picture
Figure 5. Penicillin Picture
Figure 6. Tetracyclines Picture
Figure 7. Fluoroquinolones Picture
Figure 8. Vancomycin Picture
Figure 9. Other Antibiotics Picture
Figure 10. Immunotherapy Drug Picture
Figure 11. Vaccines Picture
Figure 12. Interferon Picture
Figure 13. Pneumonia Treatment Drugs Sales Market Share by Application in 2018
Figure 14. Hospital Picture
Figure 15. Clinic Picture
Figure 16. Drugstore Picture
Figure 17. Global Pneumonia Treatment Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 18. United States Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Canada Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Mexico Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Germany Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. France Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. UK Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Russia Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Italy Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. China Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Japan Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Korea Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. India Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Southeast Asia Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Australia Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 32. Brazil Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Egypt Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Saudi Arabia Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. South Africa Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Turkey Pneumonia Treatment Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Global Pneumonia Treatment Drugs Sales Market Share by Manufacturer in 2019
Figure 38. Global Pneumonia Treatment Drugs Revenue Market Share by Manufacturer in 2019
Figure 39. Top 3 Pneumonia Treatment Drugs Manufacturer (Revenue) Market Share in 2019
Figure 40. Top 6 Pneumonia Treatment Drugs Manufacturer (Revenue) Market Share in 2019
Figure 41. Key Manufacturer Market Share Trend
Figure 42. Global Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 43. Global Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. Global Pneumonia Treatment Drugs Revenue Market Share by Regions (2015-2020)
Figure 45. Global Pneumonia Treatment Drugs Revenue Market Share by Regions in 2018
Figure 46. North America Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure 47. Europe Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure 49. South America Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure 50. Middle East & Africa Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020)
Figure 51. North America Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. North America Pneumonia Treatment Drugs Sales Market Share by Countries (2015-2020)
Figure 53. North America Pneumonia Treatment Drugs Sales Market Share by Countries in 2018
Figure 54. North America Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 55. North America Pneumonia Treatment Drugs Revenue Market Share by Countries in 2018
Figure 56. United States Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 57. Canada Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 58. Mexico Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 59. Europe Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Europe Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 61. Europe Pneumonia Treatment Drugs Revenue Market Share by Countries in 2019
Figure 62. Germany Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 63. UK Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 64. France Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 65. Russia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 66. Italy Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 67. Asia-Pacific Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. Asia-Pacific Pneumonia Treatment Drugs Sales Market Share by Regions 2019
Figure 69. Asia-Pacific Pneumonia Treatment Drugs Revenue Market Share by Regions 2019
Figure 70. China Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 71. Japan Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 72. Korea Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 73. India Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 74. Southeast Asia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 75. South America Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. South America Pneumonia Treatment Drugs Sales Market Share by Countries in 2019
Figure 77. South America Pneumonia Treatment Drugs Revenue Market Share by Countries in 2019
Figure 78. Brazil Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 79. Argentina Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 80. Middle East and Africa Pneumonia Treatment Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 81. Middle East and Africa Pneumonia Treatment Drugs Sales Market Share by Countries in 2019
Figure 82. Middle East and Africa Pneumonia Treatment Drugs Revenue Market Share by Countries (2015-2020)
Figure 83. Middle East and Africa Pneumonia Treatment Drugs Revenue Market Share by Countries in 2019
Figure 84. Saudi Arabia Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 85. Egypt Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 86. Turkey Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 87. South Africa Pneumonia Treatment Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 88. Global Pneumonia Treatment Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 89. Global Pneumonia Treatment Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 90. North America Sales Pneumonia Treatment Drugs Market Forecast (2021-2025) (MT)
Figure 91. Europe Sales Pneumonia Treatment Drugs Market Forecast (2021-2025) (MT)
Figure 92. Asia-Pacific Sales Pneumonia Treatment Drugs Market Forecast (2021-2025) (MT)
Figure 93. South America Sales Pneumonia Treatment Drugs Market Forecast (2021-2025) (MT)
Figure 94. Middle East & Africa Sales Pneumonia Treatment Drugs Market Forecast (2021-2025) (MT)
Figure 95. Sales Channel: Direct Channel vs Indirect Channel
卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…- 抗生物質薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antibiotics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibiotics Drugs market re…
- 経口セファロスポリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cephalosporin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cephalosporin market …
- オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …
- 無菌注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4258.5 million by 2025, from USD 3506.7 million in 2019. The Sterile Inj…